Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust and reproducible population receptive field mapping in patients with retinal pathologies.

Eye (London, England)·2026
Same author

Polygonal Area of Retinal Pigment Epithelium Avulsion Following Retinal Cryotherapy for Retinal Detachment.

Case reports in ophthalmological medicine·2026
Same author

Fluid Volumes Longitudinal Modeling to Predict Atrophy and Fibrosis in Neovascular Age-Related Macular Degeneration.

Ophthalmology science·2026
Same author

First-Line Faricimab in Diabetic Macular Edema: Insights from a Real-World Treatment-Naïve Population in Austria.

Journal of clinical medicine·2026
Same author

[Diagnostics, treatment and monitoring of diabetic eye disease (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

Choriocapillaris Flow-Enriched Prediction of Retinal Sensitivity Using OCT-Derived Biomarkers in Intermediate Age-Related Macular Degeneration.

Journal of clinical medicine·2026
Same journal

Erratum.

Developments in ophthalmology·2021
Same journal

Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

Developments in ophthalmology·2021
Same journal

The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

Developments in ophthalmology·2021
Same journal

Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

Developments in ophthalmology·2021
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Retinal vein occlusions.

Wolf Buehl, Stefan Sacu, Ursula Schmidt-Erfurth

    Developments in Ophthalmology
    |August 13, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Retinal vein occlusion (RVO) is a common cause of vision loss. New intravitreal anti-VEGF therapies show promise in managing RVO, with ongoing research exploring combination treatments for better outcomes.

    More Related Videos

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
    07:23

    Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

    Published on: August 6, 2021

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    Area of Science:

    • Ophthalmology
    • Vascular Medicine
    • Retinal Diseases

    Background:

    • Retinal vein occlusion (RVO) is a prevalent cause of vision impairment, particularly in older adults.
    • The complex pathophysiology of central RVO (CRVO), hemi-RVO (HRVO), and branch RVO (BRVO) necessitates an interdisciplinary approach.
    • Ischemic RVO, leading to neovascularization, is a primary driver of vision-threatening complications.

    Purpose of the Study:

    • To review current and emerging treatment strategies for RVO.
    • To highlight the impact of novel therapies on disease progression and complications.
    • To identify areas for future research in RVO management.

    Main Methods:

    • Review of evidence-based studies on RVO treatments.
    • Analysis of historical treatments including laser therapy.
    • Evaluation of recent advancements in intravitreal anti-VEGF therapy.

    Main Results:

    • Traditional treatments like grid and scatter laser therapy have established evidence.
    • Intravitreal vascular endothelial growth factor inhibitors (anti-VEGF therapy) demonstrate positive effects on RVO progression.
    • Current research is investigating various combination therapies for RVO.

    Conclusions:

    • Effective RVO management requires addressing complications and implementing prophylactic measures.
    • Anti-VEGF therapy represents a significant advancement in treating ischemic RVO.
    • Further large-scale randomized studies are needed to establish optimal treatment regimens for CRVO and BRVO.